Keep pulling the thread on Boris Jordan.
The U.S. Justice Department and the Drug Enforcement Administration (DEA) have moved to reclassify certain marijuana products to the less strictly controlled Schedule 3 category.
The reclassification of cannabis to Schedule 3 will eliminate a tax that amounted to approximately 72% of gross margin for cannabis companies.
An Administrative Law Judge (ALJ) hearing concerning the rescheduling of adult-use cannabis, which was halted during the Trump administration, is scheduled to restart on June 29th.
Curaleaf is actively engaged in M&A discussions with multiple regional and larger companies in both Europe and the United States.
Intel predicts the PC market will decline in the second half of the current year because PC makers will exhaust their memory chip inventories and face higher spot prices.
Elon Musk stated on an earnings call that his company will use Intel's 14A fabrication process.
Iran activated its air defense systems following reports of explosions near Tehran.
American Airlines lowered its full-year earnings target and stated it may end 2026 with a loss.
A merger between United Airlines and American Airlines would result in a combined domestic market share of 45%, a level that would likely be blocked by regulators.
The reclassification of cannabis to Schedule 3 will allow companies to conduct research with medical institutions and receive federal grants for that research in the United States.
Curaleaf has completed Phase 1 clinical trials in the United Kingdom for a cannabis-based neuropathic medication and is now advancing to Phase 2.
U.S. Treasury Secretary Janet Yellen has expressed support for major banking institutions providing services to the cannabis sector.